» Articles » PMID: 14693560

BlaVIM-7, an Evolutionarily Distinct Metallo-beta-lactamase Gene in a Pseudomonas Aeruginosa Isolate from the United States

Overview
Specialty Pharmacology
Date 2003 Dec 25
PMID 14693560
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

As part of the CANCER Antimicrobial Surveillance Program in North America, a Pseudomonas aeruginosa isolate, strain 07-406, was shown to possess a metallo-beta-lactamase, designated VIM-7. bla(VIM-7) is located on a 24-kb plasmid which can be readily transferred into Enterobacteriaceae and other pseudomonads. This is the first report of a mobile metallo-beta-lactamase gene, bla(VIM-7), being detected within the United States.

Citing Articles

Characterization of carbapenem-resistant Enterobacterales and carrying multiple carbapenemase genes-Antimicrobial Resistance Laboratory Network, 2018-2022.

Sabour S, Harrington K, Martinson E, Bhatnagar A, Huang J, Duffy D J Clin Microbiol. 2024; 62(12):e0122024.

PMID: 39565121 PMC: 11633150. DOI: 10.1128/jcm.01220-24.


Difficult-to-treat (DTR) harboring Verona-Integron metallo-β-lactamase (): infection management and molecular analysis.

Vega A, DeRonde K, Jimenez A, Piazza M, Vu C, Martinez O Antimicrob Agents Chemother. 2024; 68(5):e0147423.

PMID: 38602418 PMC: 11064525. DOI: 10.1128/aac.01474-23.


Selection of AmpC β-Lactamase Variants and Metallo-β-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas aeruginosa Infections.

Ruedas-Lopez A, Alonso-Garcia I, Lasarte-Monterrubio C, Guijarro-Sanchez P, Gato E, Vazquez-Ucha J Antimicrob Agents Chemother. 2021; 66(2):e0206721.

PMID: 34930034 PMC: 8846482. DOI: 10.1128/AAC.02067-21.


Complete Genome Sequence of Pseudomonas aeruginosa CMC-097, Isolated from a Ventilator-Associated Pneumonia Patient, Containing a Novel Carbapenem Resistance Class 1 Integron.

Rao J, Adenikinju A, Kerkering T, Garner D, Jensen R Microbiol Resour Announc. 2021; 10(35):e0077421.

PMID: 34472982 PMC: 8411920. DOI: 10.1128/MRA.00774-21.


Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.

Bahr G, Gonzalez L, Vila A Chem Rev. 2021; 121(13):7957-8094.

PMID: 34129337 PMC: 9062786. DOI: 10.1021/acs.chemrev.1c00138.


References
1.
Poirel L, Naas T, Nicolas D, Collet L, Bellais S, Cavallo J . Characterization of VIM-2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob Agents Chemother. 2000; 44(4):891-7. PMC: 89788. DOI: 10.1128/AAC.44.4.891-897.2000. View

2.
Coleman K, Griffin D, PAGE J, Upshon P . In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor. Antimicrob Agents Chemother. 1989; 33(9):1580-7. PMC: 172706. DOI: 10.1128/AAC.33.9.1580. View

3.
Tsakris A, Pournaras S, Woodford N, Palepou M, Babini G, Douboyas J . Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece. J Clin Microbiol. 2000; 38(3):1290-2. PMC: 88610. DOI: 10.1128/JCM.38.3.1290-1292.2000. View

4.
Toleman M, Simm A, Murphy T, Gales A, Biedenbach D, Jones R . Molecular characterization of SPM-1, a novel metallo-beta-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother. 2002; 50(5):673-9. DOI: 10.1093/jac/dkf210. View

5.
Mavroidi A, Tsakris A, Tzelepi E, Pournaras S, Loukova V, Tzouvelekis L . Carbapenem-hydrolysing VIM-2 metallo- beta-lactamase in Pseudomonas aeruginosa from Greece. J Antimicrob Chemother. 2000; 46(6):1041-2. DOI: 10.1093/jac/46.6.1041. View